Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting
